Latest News - Chemence Medical, Inc.

24

Oct

Meet us at MEDICA 2021

Meet Chemence team at Medica 2021 in Hall 16 / Booth J16 to learn about our Exofin®, DermaFlex®, Derma+Flex® QS™ High Viscosity Topical Skin Adhesives and Exofin Fusion® Wound Closure System with innovative self-adhering, curved mesh. Click here to review our showcased products and schedule appointment with Chemence | Hall 16 / J16 @ Medica Floor

5

May

Chemence Opens New Research and Development Facility

Chemence Center of Excellence to focus on adhesive technology innovation Alpharetta, GA — Chemence, a global company with specialized expertise in the field of polymerizable technology, announced the opening of the Chemence Center of Excellence, a state-of-the-art research and development facility in Alpharetta, Georgia. The facility is home to a large team of Chemence’s scientists

9

Apr

Chemence Medical Receives FDA Approval for Exofin Fusion® Redesign

Medical technologies manufacturer improves patient care with enhanced skin closure system Alpharetta, GA — Chemence Medical, a world leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion® skin closure system. Exofin fusion combines a self-adhering flexible mesh strip and a fast-curing 2-octyl

25

Feb

Chemence Medical Receives FDA Clearance for Exofin® Tissue Adhesive

Alpharetta, Georgia – February 15, 2016 Chemence Medical, Inc., a manufacturer and distributor of adhesive-based medical devices, announced it received Food and Drug Administration clearance to market and sell Exofin®, a new topical skin adhesive for wound closure. Exofin enters the market as the fastest polymerizing 2-octyl cyanoacrylate topical adhesive available and as the highest